PPAR Agonists and Cardiovascular Disease in Diabetes

Figure 5

Total aortic plaque area as assessed by an en face approach in apoE knockout mice treated with the dual PPARα/γ agonist, compound 3q for 20 weeks. P < .05 versus control mice.